In a hospital in Texas, a 56-year-old woman receives a rapid lung cancer diagnosis—not from a seasoned physician, but from...
Read moreIn recent months, a surge in healthcare worker strikes has emerged across the United States, highlighting deep-seated economic and political...
Read moreWalk through any office, airport terminal, or yoga studio in the West and you’ll likely find someone gripping a water...
Read moreIn the kaleidoscopic world of modern nutrition, villains change often. Once it was saturated fat. Then it was carbs. Now,...
Read moreIn the waiting rooms of America, a familiar ritual plays out every day. A patient glances at their phone, opens...
Read moreThere is a subtle but dangerous form of misinformation spreading — not loud and conspiratorial, but quiet and insidious. It’s...
Read moreIn 1910, Abraham Flexner published a report that would forever alter the course of American medicine. Commissioned by the Carnegie...
Read morePhysicians are no strangers to complexity. Navigating a medical diagnosis or interpreting clinical trial data can be as demanding as...
Read moreThe FDA’s Identity Crisis: Marty Makary, Mass Layoffs,and the Trump-Era Push for Speed Over Safety The U.S. Food and Drug...
Read moreGoing green is no longer optional for businesses aiming to keep up with the times, and health-care practices are no...
Read moreTelemedicine is changing the way providers practice healthcare and patients receive the care they need—here are some advancements to look...
Read moreFind out what kind of changes you can make in your hospital to support the patients under your care and...
Read moreClinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy